Mason SL - Search Results

1

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.

Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, Duran R, Mencacci NE, Sawcer SJ, Barker RA. Winder-Rhodes SE, et al. Among authors: mason sl. Brain. 2013 Feb;136(Pt 2):392-9. doi: 10.1093/brain/aws318. Brain. 2013. PMID: 23413260

2

Saccadometry: a new tool for evaluating presymptomatic Huntington patients.

Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R. Antoniades CA, et al. Among authors: mason sl. Neuroreport. 2007 Jul 16;18(11):1133-6. doi: 10.1097/WNR.0b013e32821c560d. Neuroreport. 2007. PMID: 17589313

3

Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.

Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey CE, Clough C, Brooks DJ, Barker RA, Piccini P. Reuter I, et al. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):948-51. doi: 10.1136/jnnp.2007.142380. Epub 2008 Mar 20. J Neurol Neurosurg Psychiatry. 2008. PMID: 18356253 Clinical Trial.

4

Health-related quality of life in Huntington's disease: Which factors matter most?

Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Ho AK, et al. Among authors: mason sl. Mov Disord. 2009 Mar 15;24(4):574-8. doi: 10.1002/mds.22412. Mov Disord. 2009. PMID: 19097181

5

Emerging drug therapies in Huntington's disease.

Mason SL, Barker RA. Mason SL, et al. Expert Opin Emerg Drugs. 2009 Jun;14(2):273-97. doi: 10.1517/14728210902918299. Expert Opin Emerg Drugs. 2009. PMID: 19453283

6

Visualising disease progression on multiple variables with vector plots and path plots.

Lazic SE, Mason SL, Michell AW, Barker RA. Lazic SE, et al. Among authors: mason sl. BMC Med Res Methodol. 2009 May 27;9:32. doi: 10.1186/1471-2288-9-32. BMC Med Res Methodol. 2009. PMID: 19473528 Free PMC article.

7

Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group; van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Aziz NA, et al. Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Neurology. 2009. PMID: 19776381

8

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.

Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P. Pavese N, et al. Among authors: mason sl. Neurobiol Dis. 2010 Feb;37(2):356-61. doi: 10.1016/j.nbd.2009.10.015. Epub 2009 Oct 22. Neurobiol Dis. 2010. PMID: 19853661

9

A randomized, placebo-controlled trial of latrepirdine in Huntington disease.

Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A; Huntington Disease Study Group DIMOND Investigators. Kieburtz K, et al. Arch Neurol. 2010 Feb;67(2):154-60. doi: 10.1001/archneurol.2009.334. Arch Neurol. 2010. PMID: 20142523 Free PMC article. Clinical Trial.

10

The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease.

Calder AJ, Keane J, Young AW, Lawrence AD, Mason S, Barker RA. Calder AJ, et al. Neuropsychologia. 2010 Jul;48(9):2719-29. doi: 10.1016/j.neuropsychologia.2010.05.019. Epub 2010 May 16. Neuropsychologia. 2010. PMID: 20580641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters